Application Sponsors
ANDA 091662 | LANNETT CO INC | |
Marketing Status
Application Products
001 | CAPSULE;ORAL | 12.5MG | 0 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE |
FDA Submissions
N/A; Not Applicable | ORIG | 1 | AP | 2012-01-27 | |
Submissions Property Types
CDER Filings
LANNETT CO INC
cder:Array
(
[0] => Array
(
[ApplNo] => 91662
[companyName] => LANNETT CO INC
[docInserts] => ["",""]
[products] => [{"drugName":"HYDROCHLOROTHIAZIDE","activeIngredients":"HYDROCHLOROTHIAZIDE","strength":"12.5MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"HYDROCHLOROTHIAZIDE","submission":"HYDROCHLOROTHIAZIDE","actionType":"12.5MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)